TORTORA, GIAMPAOLO
TORTORA, GIAMPAOLO
Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity.
2007 Rosano, L; DI CASTRO, V; Spinella, F; Tortora, Giampaolo; Nicotra, Mr; Natali, Pg; Bagnato, A.
ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES.
2006 Morelli, Mp; Cascone, T; Troiani, T; Tuccillo, C; Bianco, Roberto; Normanno, N; Romano, M; Veneziani, BIANCA MARIA; Fontanini, G; Eckhardt, Sg; DE PLACIDO, Sabino; Tortora, Giampaolo; Ciardiello, F.
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.
2005 Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo
MONOCLONAL ANTIBODIES TARGETING THE EPIDERMAL GROWTH FACTOR RECEPTOR.
2005 Bianco, Roberto; Daniele, Gennaro; Ciardiello, F; Tortora, Giampaolo
ANTITUMOR ACTIVITY OF ZD6474, A VEGFR-2 AND EGFR SMALL MOLECULE TYROSINE KINASE INHIBITOR, IN COMBINATION WITH SC-236, A CYCLOOXYGENASE-2 INHIBITOR.
2005 Tuccillo, C; Romano, M; Troiani, T; Martinelli, E; Morgillo, F; DE VITA, F; Bianco, Roberto; Fontanini, G; Bianco, Ar; Tortora, Giampaolo; AND CIARDIELLO, F.
Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments.
2004 Melisi, Davide; Troiani, T; Damiano, Vincenzo; Tortora, Giampaolo; Ciardiello, F.
Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies.
2007 Tortora, Giampaolo; Bianco, Roberto; Daniele, Gennaro; Ciardiello, F; Mccubrey, Ja; Ricciardi, Mr; Ciuffreda, L; Cognetti, F; Tafuri, A; Milella, M.
Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.
2006 Bianco, C; Giovannetti, E; Ciardiello, F; Mey, V; Nannizzi, S; Tortora, Giampaolo; Troiani, T; Pasqualetti, F; Eckhardt, G; DE LIGUORO, M; Ricciardi, S; DEL TACCA, M; Raben, D; Cionini, L; Danesi, R.
Combination of biological therapies in non-small cell lung cancer.
2006 Bianco, Roberto; Damiano, Vincenzo; Tortora, Giampaolo
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors.
2005 M. P., Morelli; T., Cascone; Troiani, Teresa; F., De Vita; M., Orditura; Laus, Gianluca; S. G., Eckhardt; Pepe, Stefano; Tortora, Giampaolo; F. C. i. a. r. d. i. e. l. l., O.
TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.
2007 Damiano, V; Caputo, R; Garofalo, S; Bianco, Roberto; Rosa, R; Merola, G; Gelardi, T; Racioppi, Luigi; Fontanini, G; DE PLACIDO, Sabino; Kandimalla, Er; Agrawal, S; Ciardiello, F; Tortora, Giampaolo
The rationale for the combination of selective EGFR inhibitors with cytotoxic drugs and radiotherapy.
2007 Tortora, Giampaolo; Gelardi, T; Ciardiello, F; Bianco, Roberto
Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy.
2007 Morgillo, F; Bareschino, Ma; Bianco, Roberto; Tortora, Giampaolo; Ciardiello, F.
Key cancer cell signal transduction pathways as therapeutic targets.
2006 Bianco, Roberto; Melisi, Davide; Ciardiello, F; Tortora, Giampaolo
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study.
2007 DI LORENZO, G; Autorino, R; Perdona, S; DE LAURENTIIS, Michelino; D'Armiento, FRANCESCO PAOLO; Cancello, G; Mirone, Vincenzo; Imbimbo, Ciro; Longo, Nicola; Altieri, Vincenzo; Tortora, Giampaolo; Figg, Wd; DE PLACIDO, Sabino
Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells.
1995 Damiano, Vincenzo; F., Ciardiello; C., Bianco; G., Baldassarre; G., Di Isernia; Pepe, Stefano; A., Ruggiero; G., Merlo; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo
Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A.
1997 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Pepe, Stefano; Bianco, Ar; Jiang, Z; Agrawal, S; Ciardiello, F.
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J Natl Cancer Inst. 1996 Dec 4;88(23):1770-6.
1996 Ciardiello, F; Damiano, V; Bianco, Roberto; Bianco, C; Fontanini, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Mendelsohn, J; Bianco, Ar; Tortora, Giampaolo
Angiogenesis: A target for cancer therapy.
2004 Tortora, Giampaolo; Melisi, Davide; Ciardiello, F.
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
2004 Raben, D; Bianco, C; Damiano, Vincenzo; Bianco, Roberto; Melisi, Davide; Mignogna, C; D'Armiento, FRANCESCO PAOLO; Cionini, L; Bianco, Ar; Tortora, Giampaolo; Ciardiello, F; Bunn, P.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity. | 1.1 Articolo in rivista | 2007 | Rosano, L; DI CASTRO, V; Spinella, F; Tortora, Giampaolo; Nicotra, Mr; Natali, Pg; Bagnato, A. | |
| ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES. | 1.1 Articolo in rivista | 2006 | Morelli, Mp; Cascone, T; Troiani, T; Tuccillo, C; Bianco, Roberto; Normanno, N; Romano, M; Veneziani, BIANCA MARIA; Fontanini, G; Eckhardt, Sg; DE PLACIDO, Sabino; Tortora, Giampaolo; Ciardiello, F. | |
| Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. | 1.1 Articolo in rivista | 2005 | Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo | |
| MONOCLONAL ANTIBODIES TARGETING THE EPIDERMAL GROWTH FACTOR RECEPTOR. | 1.1 Articolo in rivista | 2005 | Bianco, Roberto; Daniele, Gennaro; Ciardiello, F; Tortora, Giampaolo | |
| ANTITUMOR ACTIVITY OF ZD6474, A VEGFR-2 AND EGFR SMALL MOLECULE TYROSINE KINASE INHIBITOR, IN COMBINATION WITH SC-236, A CYCLOOXYGENASE-2 INHIBITOR. | 1.1 Articolo in rivista | 2005 | Tuccillo, C; Romano, M; Troiani, T; Martinelli, E; Morgillo, F; DE VITA, F; Bianco, Roberto; Fontanini, G; Bianco, Ar; Tortora, Giampaolo; AND CIARDIELLO, F. | |
| Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments. | 1.1 Articolo in rivista | 2004 | Melisi, Davide; Troiani, T; Damiano, Vincenzo; Tortora, Giampaolo; Ciardiello, F. | |
| Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies. | 1.1 Articolo in rivista | 2007 | Tortora, Giampaolo; Bianco, Roberto; Daniele, Gennaro; Ciardiello, F; Mccubrey, Ja; Ricciardi, Mr; Ciuffreda, L; Cognetti, F; Tafuri, A; Milella, M. | |
| Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer. | 1.1 Articolo in rivista | 2006 | Bianco, C; Giovannetti, E; Ciardiello, F; Mey, V; Nannizzi, S; Tortora, Giampaolo; Troiani, T; Pasqualetti, F; Eckhardt, G; DE LIGUORO, M; Ricciardi, S; DEL TACCA, M; Raben, D; Cionini, L; Danesi, R. | |
| Combination of biological therapies in non-small cell lung cancer. | 1.1 Articolo in rivista | 2006 | Bianco, Roberto; Damiano, Vincenzo; Tortora, Giampaolo | |
| Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors. | 1.1 Articolo in rivista | 2005 | M. P., Morelli; T., Cascone; Troiani, Teresa; F., De Vita; M., Orditura; Laus, Gianluca; S. G., Eckhardt; Pepe, Stefano; Tortora, Giampaolo; F. C. i. a. r. d. i. e. l. l., O. | |
| TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts. | 1.1 Articolo in rivista | 2007 | Damiano, V; Caputo, R; Garofalo, S; Bianco, Roberto; Rosa, R; Merola, G; Gelardi, T; Racioppi, Luigi; Fontanini, G; DE PLACIDO, Sabino; Kandimalla, Er; Agrawal, S; Ciardiello, F; Tortora, Giampaolo | |
| The rationale for the combination of selective EGFR inhibitors with cytotoxic drugs and radiotherapy. | 1.1 Articolo in rivista | 2007 | Tortora, Giampaolo; Gelardi, T; Ciardiello, F; Bianco, Roberto | |
| Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy. | 1.1 Articolo in rivista | 2007 | Morgillo, F; Bareschino, Ma; Bianco, Roberto; Tortora, Giampaolo; Ciardiello, F. | |
| Key cancer cell signal transduction pathways as therapeutic targets. | 1.1 Articolo in rivista | 2006 | Bianco, Roberto; Melisi, Davide; Ciardiello, F; Tortora, Giampaolo | |
| Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study. | 1.1 Articolo in rivista | 2007 | DI LORENZO, G; Autorino, R; Perdona, S; DE LAURENTIIS, Michelino; D'Armiento, FRANCESCO PAOLO; Cancello, G; Mirone, Vincenzo; Imbimbo, Ciro; Longo, Nicola; Altieri, Vincenzo; Tortora, Giampaolo; Figg, Wd; DE PLACIDO, Sabino | |
| Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells. | 1.1 Articolo in rivista | 1995 | Damiano, Vincenzo; F., Ciardiello; C., Bianco; G., Baldassarre; G., Di Isernia; Pepe, Stefano; A., Ruggiero; G., Merlo; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo | |
| Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A. | 1.1 Articolo in rivista | 1997 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Pepe, Stefano; Bianco, Ar; Jiang, Z; Agrawal, S; Ciardiello, F. | |
| Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J Natl Cancer Inst. 1996 Dec 4;88(23):1770-6. | 1.1 Articolo in rivista | 1996 | Ciardiello, F; Damiano, V; Bianco, Roberto; Bianco, C; Fontanini, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Mendelsohn, J; Bianco, Ar; Tortora, Giampaolo | |
| Angiogenesis: A target for cancer therapy. | 1.1 Articolo in rivista | 2004 | Tortora, Giampaolo; Melisi, Davide; Ciardiello, F. | |
| Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. | 1.1 Articolo in rivista | 2004 | Raben, D; Bianco, C; Damiano, Vincenzo; Bianco, Roberto; Melisi, Davide; Mignogna, C; D'Armiento, FRANCESCO PAOLO; Cionini, L; Bianco, Ar; Tortora, Giampaolo; Ciardiello, F; Bunn, P. |